Sections
Shortcuts
Business

Carlyle Group makes $4.15B offer for J&J business

Johnson & Johnson has until March 31 to decided whether to sell its Ortho-Clinical Diagnostics business,
Johnson & Johnson has until March 31 to decided whether to sell its Ortho-Clinical Diagnostics business, Associated Press/File 2013

This is a summary. To read the whole story subscribe to BostonGlobe.com

Johnson & Johnson said Thursday that it’s been offered $4.15 billion by The Carlyle Group for its Ortho-Clinical Diagnostics business, a year after J&J began reviewing strategic options for the blood-testing unit as part of a routine pruning of its extensive family of businesses.

J&J, based in New Brunswick, N.J., has until March 31 to decide whether to accept the offer. Johnson & Johnson executives plan to discuss the offer Tuesday, when the health giant and consumer products company reports fourth-quarter results. The company said Thursday that it will consult with works councils and trade unions representing the unit’s employees before making a decision.

Full story for BostonGlobe.com subscribers.

Get the full story with unlimited access to BostonGlobe.com.

Just 99 cents for four weeks.

Sections
Shortcuts

Share